Amgen is trading at $348.22 (6.3% down) in after-hours trading, moving lower alongside a broader market retreat.

  • The stock saw a sharp decline from its regular-session close of $371.50 despite a lack of company-specific news or earnings reports.
  • The move appears driven by a risk-off tape as major indices fall, with limited after-hours liquidity likely amplifying the selling pressure.